Concepedia

Publication | Open Access

Potent Twice-Weekly Rifapentine-containing Regimens in Murine Tuberculosis

DOIFull Paper Access

89

Citations

31

References

2006

Year

Ian M. Rosenthal, Kathy N. Williams, Sandeep Tyagi, Charles A. Peloquin, Andrew Vernon, William R. Bishai, J Grosset, Eric Nuermberger
American Journal of Respiratory and Critical Care Medicine

Abstract

By virtue of the enhanced rifamycin exposure, twice-weekly regimens containing rifapentine (15 or 20 mg/kg) may permit shortening the current treatment duration by 2 mo. Such regimens warrant clinical investigation.

References

YearCitations

Page 1